These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3225758)

  • 1. Stereoselective gastrointestinal clearance of disopyramide in rabbits treated with activated charcoal.
    Huang JD
    J Pharm Sci; 1988 Nov; 77(11):959-62. PubMed ID: 3225758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal dialysis of disopyramide in healthy subjects.
    Arimori K; Kawano H; Nakano M
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):280-4. PubMed ID: 2737797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on transport of disopyramide into the intestinal lumen aimed at gastrointestinal dialysis by activated charcoal in rats.
    Arimori K; Nakano M
    J Pharm Pharmacol; 1989 Jul; 41(7):445-9. PubMed ID: 2570848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of electrocardiographic response and disposition of R- and S-disopyramide in the rabbit.
    Huang JD; Oie S
    Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):227-41. PubMed ID: 6635318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of theophylline clearance in gastrointestinal dialysis with charcoal.
    Huang JD
    J Pharm Sci; 1987 Jul; 76(7):525-7. PubMed ID: 3668813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective pharmacokinetics of disopyramide enantiomers in man.
    Lima JJ; Boudoulas H; Shields BJ
    Drug Metab Dispos; 1985; 13(5):572-7. PubMed ID: 2865105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective metabolism and pharmacokinetics of disopyramide enantiomers in humans.
    Le Corre P; Gibassier D; Sado P; Le Verge R
    Drug Metab Dispos; 1988; 16(6):858-64. PubMed ID: 2907466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dose of charcoal on the absorption of disopyramide, indomethacin and trimethoprim by man.
    Neuvonen PJ; Olkkola KT
    Eur J Clin Pharmacol; 1984; 26(6):761-7. PubMed ID: 6489417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct enantiomeric resolution of disopyramide and its metabolite using chiral high-performance liquid chromatography. Application to stereoselective metabolism and pharmacokinetics of racemic disopyramide in man.
    Le Corre P; Gibassier D; Sado P; Le Verge R
    J Chromatogr; 1988 Oct; 450(2):211-6. PubMed ID: 3235589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stereoselective disposition of disopyramide in the dog.
    Giacomini KM; Giacomini JC; Swezey SE; Harrison DC; Nelson WL; Burke TR; Blaschke TF
    J Cardiovasc Pharmacol; 1980; 2(6):825-32. PubMed ID: 6160331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog.
    Cook CS; Karim A; Sollman P
    Drug Metab Dispos; 1982; 10(2):116-21. PubMed ID: 6124395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective disposition and metabolism of disopyramide in pediatric patients.
    Echizen H; Takahashi H; Nakamura H; Ochiai K; Chiba K; Koike K; Ogata H; Ishizaki T
    J Pharmacol Exp Ther; 1991 Dec; 259(3):953-60. PubMed ID: 1762088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of serum protein binding on hepatic clearance of S-disopyramide in the rabbit.
    Huang JD; Oie S
    J Pharm Pharmacol; 1985 Jul; 37(7):471-5. PubMed ID: 2863349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal dialysis of digoxin using cholestyramine.
    Rawashdeh NM; al-Hadidi HF; Irshaid YM; Battah AK
    Pharmacol Toxicol; 1993; 72(4-5):245-8. PubMed ID: 8372041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of activated charcoal on the disposition kinetics of methamphetamine enantiomers in the rat following intravenous dosing.
    Hutchaleelaha A; Mayersohn M
    J Pharm Sci; 1996 May; 85(5):541-5. PubMed ID: 8742948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral activated charcoal on the pharmacokinetics of quinidine and quinine administered intravenously to rabbits.
    Hasan MM; Hassan MA; Rawashdeh NM
    Pharmacol Toxicol; 1990 Jul; 67(1):73-6. PubMed ID: 2395819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective pharmacokinetics and pharmacodynamics of disopyramide and its metabolite in rabbits.
    Horikawa M; Yasumuro M; Kanno M; Hanada K; Hashiguchi M; Ogata H
    J Pharm Pharmacol; 2001 Dec; 53(12):1621-8. PubMed ID: 11804392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of oral activated charcoal on the systemic clearance of gentamicin in rabbits with acute renal failure.
    Hasan MM; el-Sayed YM; Abdelaziz AA
    J Pharm Pharmacol; 1990 Feb; 42(2):85-8. PubMed ID: 1972407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselective biliary elimination of disopyramide and mono-N-desisopropyldisopyramide in humans.
    le Corre P; Malledant Y; Chevanne F; Sado P; le Verge R
    Chirality; 1992; 4(2):80-3. PubMed ID: 1616827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective pharmacokinetics of disopyramide and interaction with cimetidine.
    Bonde J; Pedersen LE; Nygaard E; Ramsing T; Angelo HR; Kampmann JP
    Br J Clin Pharmacol; 1991 Jun; 31(6):708-10. PubMed ID: 1867965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.